NAD+ (Nicotinamide Adenine Dinucleotide): Coenzyme Biochemistry and Sirtuin Research

Discovery and Scientific History

Nicotinamide adenine dinucleotide (NAD+) was first discovered in 1906 by Arthur Harden and William John Young during their studies of yeast fermentation at the Lister Institute in London. They identified a heat-stable, low-molecular-weight factor essential for alcoholic fermentation—initially termed "cozymase." The complete chemical structure was elucidated by Hans von Euler-Chelpin in the 1930s, work that contributed to his 1929 Nobel Prize in Chemistry (shared with Harden). The modern understanding of NAD+ as a central metabolic coenzyme was established through the work of Otto Warburg, who characterized its role in hydrogen transfer reactions.

Chemical Structure

NAD+ is a dinucleotide consisting of two nucleotides joined through their phosphate groups. Molecular formula: C₂₁H₂₇N₇O₁₄P₂, molecular weight: 663.4 Da.

• Nicotinamide moiety: the catalytically active portion that accepts and donates hydride ions (H⁻) during redox reactions
• Adenine moiety: provides structural recognition for enzyme binding
• Two ribose sugars: connected by a pyrophosphate bridge

The NAD⁺/NADH redox couple has a standard reduction potential of −320 mV, positioning it as a central electron carrier in catabolic metabolism. The oxidized form (NAD⁺) and reduced form (NADH) interconvert in over 500 enzymatic reactions in mammalian cells.

Biological Functions

Redox Metabolism

NAD+ serves as the primary electron acceptor in glycolysis (glyceraldehyde-3-phosphate dehydrogenase), the citric acid cycle (isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, malate dehydrogenase), and fatty acid β-oxidation. The NADH produced feeds the mitochondrial electron transport chain at Complex I (NADH:ubiquinone oxidoreductase).

Sirtuin Activation

Perhaps the most active area of contemporary NAD+ research involves the sirtuins (SIRT1-7), a family of NAD+-dependent protein deacetylases and ADP-ribosyltransferases. Sirtuins consume NAD+ as a co-substrate (not merely a cofactor), cleaving it to generate nicotinamide and O-acetyl-ADP-ribose while removing acetyl groups from target proteins.

Reference: Imai S et al. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-71.

PARP-Mediated DNA Repair

Poly(ADP-ribose) polymerases (PARPs) are another major class of NAD+-consuming enzymes. PARP1 detects single-strand DNA breaks and uses NAD+ to synthesize poly(ADP-ribose) chains that recruit DNA repair machinery. Under conditions of extensive DNA damage, PARP hyperactivation can deplete cellular NAD+ pools.

CD38 and Calcium Signaling

CD38, a transmembrane glycoprotein with NADase activity, is the primary NAD+-consuming enzyme in mammalian tissues. It catalyzes the conversion of NAD+ to cyclic ADP-ribose (cADPR), a potent mobilizer of intracellular calcium stores through ryanodine receptor activation.

Key Published Studies

• Yoshino J et al. (2011) — Demonstrated age-related decline in NAD+ biosynthesis in murine tissue models.
• Cantó C et al. (2015) — Comprehensive review of NAD+ metabolism and its signaling roles, published in Cell Metabolism.
• Rajman L et al. (2018) — Review of NAD+ precursors and NAD+ biology in aging research.

Future Research Directions

Active areas include characterization of compartmentalized NAD+ pools (nuclear, cytoplasmic, mitochondrial), investigation of the CD38-NAD+-sirtuin regulatory axis, and development of NAD+ biosensor tools for real-time monitoring of cellular NAD+ dynamics.

Available at Crush Research: NAD+ 1000mg. View Certificates of Analysis.

All products are intended for in vitro and laboratory research use only. Not for human or veterinary use.